PSAT1 overexpression correlates to poor prognosis in colon cancer, non-small cell lung cancer and breast cancer (Martens et al., 2005; Pollari et al., 2012; Vié et al., 2008; Yang et al., 2015). Here, PSAT1 is linked to breast cancer.